Angiex was founded by world-class scientists to develop vascular-targeted biotherapeutics. Angiex targets fundamental aspects of endothelial biology with a focus on angiogenesis.

Biotechnology

Angiex

Angiex's headquarters in Cambridge, MA, United States

Shou-Ching Jaminet

Paul Jaminet

Jeff Sacher

Joshua H.

Glen Weiss

Elie Tabet

Fabian Hansen

Jason Camm

Errik Anderson

Hal Dvorak

Karen Chu

Iain Dukes

The Scientific Team at Angiex conducts cutting-edge research to develop innovative vascular-targeted biotherapeutics. With expertise in endothelial biology, angiogenesis, and advanced imaging techniques, the team works to discover and advance novel therapies from concept through to preclinical validation.

Scientific Team

The Leadership Team at Angiex is responsible for guiding the strategic direction of the company and overseeing the development of innovative vascular-targeted biotherapeutics. Comprising visionary founders with deep expertise in science and operations, the team fosters a collaborative environment to drive research initiatives, ensure regulatory compliance, and position the company at the forefront of angiogenesis-focused biopharmaceutical advancements.

Leadership Team

Angiex

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Angiex

Org chart

Board & advisors

Teams

Scientific Team

Leadership Team

Offices

Related companies